It should be noted that Pune IBS has already started Phase II and III of the Oxford COVID vaccine in India last week. About 1,600 volunteers will be enrolled for the critical last stage of the Oxford vaccine trials. AstraZeneca has also started the final phase of testing in the US, where approximately 30,000 participants will enroll. The drugmaker is expected to conduct human trials soon in Russia and Japan.
In a positive development, British-Swedish pharmaceutical company AstraZeneca could publish the first results on the efficacy of the vaccine to contain the spread of the new coronavirus in mid-September. According to Airfinity Ltd, which is a testing company, two other main competitors in the race to produce a safe and effective vaccine, Moderna Inc and Pfizer Inc. and BioNTech SE can also keep preliminary vaccine data ready by October 22. 2020.
It should be noted that a major Food and Drug Administration meeting on vaccine candidate development is scheduled for Oct. 22, according to a Bloomberg report.
.
